References
- Lenoir Labayle C., Buffet D. C, Laurial H, Blanchon P, Etienne JP. Hépatite à la clométacine. Nouv Press? Méd 1978; 7: 3035–3036
- Goldfarb G, Pessayre D, Boisseau L, Degott C, Béraud C, Benhamou JP. Hépatite à la clométacine. Gastronentérol. Clin Biol 1979; 3: 537–540
- Hillion D, Felsenheld C, Oberlin P, Eugène C, Bruet A. Péricholangite chez un adulte traite par clométacine. Gastroentérol. Clin Biol 1983; 7: 1038–1039, letter
- Lamouliatte H, Quinton A, Becouard Y, Delteil L. Clométacine, hépatite chronique active et marqueurs d'autoimmunité. Gastroentérol. Clin Biol 1982; 6: 715–716, letter
- Mamou P, Lévy VG. Atteintes hépatiques aprés clométacine. 6 cas dont 2 mortels. Nouv Presse Méd 1981; 10: 2719–2722
- Métreau JM, André C., Zafrani E S, Saint-Marc Girardin M F, Caruana A, Dhumeaux D. Hépatites chroniques actives associées à des anticorps anti-ADN natif: frequence de l'étiologie médicamenteuse. Gastroentérol. Clin Biol 1984; 8: 833–837
- Pessayre D, Degos F, Feldmann G, Degott Bernuau C. J, Benhamou JP. Chronic hepatitis and giant multinucleated hepatocytes in adults treated with clometacin. Digest 1981; 22: 66–72
- Petit J, Moreau A, Legendre C, Bodin F. Hepatite chronique active à la clométacine; deux observations. Gastroentérol. Clin Biol 1981; 5: 1068–1969, letter
- Poitrine Poinard A. R., Naveau S, Hilpert G, Chaput JC. Un nouveau cas mortel d'hépatite à la clométacine. Gastroentérol. Clin Biol 1983; 7: 99, letter
- Dangoumau J, Evreux J G, Jouglard J. Méthode d'imputabilité des effets indésirables des medicaments. Théraple 1978; 33: 373–380
- Karch F E, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247–254
- Roitt I M, Doniach D. Immunofluorescent tests for the detection of auto-antibodies. WHO booklet on immunological techniques. WHO, Geneva 1972; 1–12
- Homberg J C, André C, Abuaf N. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol 1984; 55: 561–570
- Homberg J C, Stelly N, Andreis I, Abuaf N, Saadoun F, André J. A new anti-mitochondria antibody (anti-M6) in iproniazid-induced hepatitis. Clin Exp Immunol 1982; 47: 93–102
- Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 1979; 38: 621–628
- Zimmerman HJ. Hepatotoxicity (the adverse effects of drugs and other chemicals on the liver). Appleton Century-Crofts, New-York 1978; 110–114
- Homberg J C, Abuaf N, Helmy-Khalil S, Biour M, Poupon R, Islam S, Darnis F, Lévy VG, Abuaf N, Helmy-Khalil S, Biour M, Poupon R, Islam S, Darnis F, Lévy VG, Opolon P, Beaugrand M, Toulet J, Danan G, Benhamou JP. Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatol 1985; 5: 722–727
- Cooksley W GE, Cowen A E, Powell LW. The incidence of oxyphenisatin ingestion in active chronic hepatitis: a prospective controlled study of 29 patients. Aust N Z J Med 1973; 3: 124–128
- Delchier J C, Métreau JM, Lévy VG, Opolon P, Dhumeaux D. L'oxyphénisatine, laxatif responsable d'hépatites chroniques et de cirrhoses … toujours commercialisé en France. Nouv Presse Méd 1979; 8: 2955–2958
- Gjone E, Blomhoff J P, Ritland S, Elgjo K, Husby G. Laxative-induced chronic liver disease. Scan J Gastroenterol 1972; 7: 395–402
- Reynolds T B, Peters R L, Yamada S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Eng J Med 1971; 285: 813–820
- Rodman J S, Deutsch D J, Gutman SI. Methyldopa hepatitis: A report of six cases and review of the literature. Am J Med 1976; 60: 941–948
- Black M, Rabin L, Schatz N. Nitrofurantoin-induced chronic active hepatitis. Ann Int Med 1980; 92: 62–64
- Sharp J R, Ishak K G, Zimmerman HJ. Chronic active hepatitis in severe hepatic necrosis associated with nitrofurantoin. Ann Int Med 1980; 92: 14–19
- Ronnov-Jenssen V, Tjerlund A. Hepatotoxicity due to treatment with papverine: Report of four cases. N Eng J Med 1969; 281: 1333–1339
- Zimmerman HJ. Hepatotoxicity (the adverse effects of drugs and other chemicals on the liver). Appleton Century-Crofts, New-York 1978; 548–550